相关实验视频
Updated: Jan 14, 2026

08:05
Murine Model of Allergen Induced Asthma
Published on: May 14, 2012
41.2K
泌尿酸酶等离子素激活器受体减弱过敏原诱导的乙氨基菌迁移和气道过敏反应
Gregory S Whitehead1, Keiko Nakano2, Christina L Wilkinson3
1National Institute of Environmental Health Sciences, Immunity, Inflammation, and Disease Laboratory, Durham, North Carolina, United States.
American journal of respiratory cell and molecular biology
|October 24, 2025
概括
泌尿酸酶等离子素激活体受体 (uPAR) 在过敏性喘中起着双重作用,通过埃索因菲尔影响呼吸道炎症,并通过上皮细胞影响呼吸道过敏反应. 准UPAR可能为喘提供治疗益处.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 分子生物学分子生物学
背景情况:
- 过敏性喘是一种慢性呼吸道疾病,涉及多种细胞类型.
- 泌尿酸酶等离子体激活器受体 (uPAR) 涉及白细胞功能,在喘患者中升高.
- uPAR在过敏性喘发病的具体作用尚不清楚.
研究的目的:
- 调查UPAR在过敏性喘发展中的作用.
- 阐明UPAR在气道炎症和气道过敏反应 (AHR) 中的独特作用.
主要方法:
- 利用多个小鼠菌株和过敏呼吸道疾病模型.
- 在过敏敏感和挑战期间分析了Plaur (编码UPAR的基因) 的诱导.
- 产生并研究了具有选择性Plaur缺乏症的小鼠在乙素和肺上皮细胞中.
主要成果:
- 在喘模型中,斑块缺乏的小鼠表现出高氨基和AHR的增加.
- 叶绿素细胞中Plaur的损失增强了它们的迁移,但没有增加AHR.
- 肺上皮细胞中Plaur的损失增加了AHR,但没有增加炎症.
结论:
- uPAR通过不同的细胞机制调节气道炎症和AHR.
- uPAR在乙酸细胞迁移中的作用有助于炎症.
- uPAR在肺上皮细胞中的作用对于控制AHR至关重要.
- 准UPAR为喘治疗提供了一个潜在的治疗策略.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Allergic Reactions
32.0K
Overview
32.0K
Antiasthma Drugs: Leukotriene Modifiers
1.7K
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
1.7K
Asthma-I: Introduction
3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K

